Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000490081 | SCV000577151 | pathogenic | not provided | 2021-12-14 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek 2016); Observed in individuals with a personal or family history consistent with pathogenic variants in this gene referred for genetic testing at GeneDx and in published literature (Giugliano 2019, Kang 2020); This variant is associated with the following publications: (PMID: 31370276, 31776437) |
Labcorp Genetics |
RCV003766748 | SCV004641385 | pathogenic | Neurofibromatosis, type 1 | 2023-09-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 426651). This premature translational stop signal has been observed in individual(s) with neurofibromatosis type 1 (PMID: 31370276, 31776437). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.His415Profs*14) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). |